本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

21.64
+0.22001.03%
盘后22.070.4300+1.99%16:19 EST
成交量:222.21万
成交额:4,820.48万
市值:27.66亿
市盈率:120.22
高:22.12
开:21.44
低:20.82
收:21.42
52周最高:30.48
52周最低:16.10
股本:1.28亿
流通股本:7,811.99万
量比:0.91
换手率:2.84%
股息:- -
股息率:- -
每股收益(TTM):0.1800
每股收益(LYR):0.1775
净资产收益率:7.48%
总资产收益率:3.53%
市净率:7.47
市盈率(LYR):121.93

数据加载中...

2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities